Adamis Pharmaceuticals Corporation (Nasdaq: ADMP) has entered into an exclusive licensing agreement with Allergan plc’s (NYSE: AGN) wholly owned subsidiary ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE